Your session is about to expire
← Back to Search
Other
1 for Diabetes
Phase 1
Waitlist Available
Research Sponsored by GAAD Medical Research Institute Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Persons with type 1 or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
A study to determine the use of far infrared (FIR) radiation for treatment of diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The primary end point is to determine the therapeutic effects of far infrared radiation on all types of diabetes.
Secondary outcome measures
Adrenal gland hypofunction
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
GAAD Medical Research Institute Inc.Lead Sponsor
21 Previous Clinical Trials
93 Total Patients Enrolled
Ken Nedd, M.D.Study DirectorGAAD Medical Research Institute Inc.
19 Previous Clinical Trials
91 Total Patients Enrolled
Kwasi Donyina, Ph.D.Study ChairGAAD Medical Research Institute Inc.
13 Previous Clinical Trials
52 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger